Cecilia S. Seguin
Campinas, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CGE26-320: Influence of SLC Genes Variants and Patient Ancestry on Adverse Reactions Induced by Carboplatin and Paclitaxel in Patients With Lung Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 16, 2026
CGE26-320: Influence of SLC Genes Variants and Patient Ancestry on Adverse Reactions Induced by Carboplatin and Paclitaxel in Patients With Lung Cancer.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 01, 2026
Association of ABC Efflux Transporter Genetic Variants and Adverse Drug Reactions and Survival in Patients with Non-Small Lung Cancer.
Journal: Genes
Published: March 12, 2025
Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 05, 2024
Genetic Variants in the ABCB1 and ABCG2 Gene Drug Transporters Involved in Gefitinib-Associated Adverse Reaction: A Systematic Review and Meta-Analysis.
Journal: Genes
Published: April 09, 2024
hsa‑miR‑455‑3P as a predictive biomarker of anemia in patients with non‑small cell lung cancer treated with carboplatin plus paclitaxel.
Journal: Oncology letters
Published: June 26, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026